Company news
Inhalation Sciences Sweden AB news in 2025
Inhalation Sciences Sweden AB's news releases, calls and decks from 2025, newest first.
Inhalation Sciences receives major IRS order for DissolvIt® from leading global pharma company
December 22, 2025
Inhalation Sciences: Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference
December 11, 2025
Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market
December 4, 2025
ISAB: Revenue fell, losses widened, but order intake and cash position improved after new financing
November 21, 2025
Inhalation Sciences: Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations
November 4, 2025
Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations
November 4, 2025
Inhalation Sciences: Inhalation Sciences receives IRS order from leading European university hospital
October 24, 2025
Inhalation Sciences receives IRS order from leading European university hospital
October 24, 2025
Inhalation Sciences: Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference
October 7, 2025
Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference
October 7, 2025
Inhalation Sciences: Inhalation Sciences receives service orders from recurring global pharma customers
October 2, 2025
Inhalation Sciences receives service orders from recurring global pharma customers
October 2, 2025
Inhalation Sciences: University of Liège highlights the value of PreciseInhale® in advancing Inhalation Research
September 19, 2025
Inhalation Sciences: Inhalation Sciences launches marketing campaign to increase awareness
September 17, 2025
Inhalation Sciences launches marketing campaign to increase awareness
September 17, 2025
ISAB: Revenue fell sharply, but cost cuts and new funding support a push toward profitability
August 29, 2025
Inhalation Sciences: Inhalation Sciences receives service order from recurring global pharmaceutical customer
July 1, 2025
ISAB: Record order backlog and FDA validation drive growth plans despite widening losses
May 16, 2025
ISAB: Revenue declined and losses increased, but FDA validation and new funding aim to drive growth
February 28, 2025
Decks in 2025
- Technical Presentation (May 2025)
Technical · 22 slides · May 28, 2025